Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Pharmacogenetics of Aromatase Inhibitors in Endocrine Responsive Breast Cancer: Lessons Learnt from Tamoxifen and CYP2D6 Genotyping.

Baatjes KJ, Conradie M, Apffelstaedt JP, Kotze MJ.

Anticancer Agents Med Chem. 2017;17(13):1805-1813. doi: 10.2174/1871521409666170412124226. Review.

PMID:
28403774
2.

A logistic equation to determine the validity of tramadol from related gene polymorphisms and psychological factors.

Zhao Q, Sun J, Tao Y, Wang S, Jiang C, Zhu Y, Yu F, Zhu J.

Pharmacogenomics. 2014 Mar;15(4):487-95. doi: 10.2217/pgs.14.22.

PMID:
24624916
3.

The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients.

Wesmiller SW, Henker RA, Sereika SM, Donovan HS, Meng L, Gruen GS, Tarkin IS, Conley YP.

Biol Res Nurs. 2013 Oct;15(4):382-9. doi: 10.1177/1099800412449181. Epub 2012 Jun 20.

4.

Drug interaction potential of toremifene and N-desmethyltoremifene with multiple cytochrome P450 isoforms.

Kim J, Peraire C, SolĂ  J, Johanning KM, Dalton JT, Veverka KA.

Xenobiotica. 2011 Oct;41(10):851-62. doi: 10.3109/00498254.2011.590546. Epub 2011 Jul 5.

PMID:
21726172
5.
6.

Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia.

Bonanni B, Serrano D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Macis D, Cazzaniga M, Luini A, Cassano E, Oldani S, Lien EA, Pelosi G, Decensi A.

Clin Cancer Res. 2009 Nov 15;15(22):7053-60. doi: 10.1158/1078-0432.CCR-09-1354. Epub 2009 Nov 3.

7.

Complicated pain management in a CYP450 2D6 poor metabolizer.

Foster A, Mobley E, Wang Z.

Pain Pract. 2007 Dec;7(4):352-6. Epub 2007 Nov 6.

PMID:
17986163

Supplemental Content

Loading ...
Support Center